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Pr ecis: The SNP-array-based genomic signature of BRCA1/2 inactivation in basal-like breast carcinoma described in this study may greatly ease the practical challenges of selecting patients for genetic testing or for recruitment to clinical trials of emerging therapies that target DNA repair deficiencies in cancer. Pr ecis: These findings deepen insights into the potent effects of p53 on stem cell prowess, which may yet prove to be of great importance in understanding not only the roots of cancer but also how to eradicate it.
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ABOUT THE COVER
The GPI-linked cell surface glycoprotein, CD24, has been shown to be a biomarker of and contributor to carcinogenesis and metastasis in several tumor types. The transcription factor, HIF-1a, plays a key role in physiologic and neoplastic hypoxia, regulating expression of several oncogenic transcriptional targets. Herein, Thomas and colleagues provide a mechanistic link between these two key proteins in cancer biology by showing that HIF-1a directly regulates CD24 at its promoter and that the prometastatic activity of HIF-1a in experimental metastasis models of bladder and prostate cancer depends on CD24 expression. Immunohistochemical studies using human bladder cancer tissues (pictured on cover) found that expression of HIF-1a and CD24 was correlated, whereas simultaneous low expression of these biomarkers was associated with the best overall patient survival, supporting the clinical relevance of this pathway. For details, see article by Thomas and colleagues on page 5600. To request permission to re-use all or part of this article, contact the AACR Publications Department at
